All‐cause mortality Up to 28 days following admission · individuals with influenza
It is very uncertain whether corticosteroid therapy changes number of deaths at 30 days following admission (30‐day mortality)a compared with no corticosteroid therapy (very low certainty).
1 finding from 1 review
Incidence of admissions to the ICU · individuals with influenza
It is very uncertain whether corticosteroid therapy changes rate of admission to intensive care units compared with no corticosteroid therapy (very low certainty).
1 finding from 1 review
Number and nature of adverse events secondary to corticosteroid use (hospital‐acquired infection) · individuals with influenza
It is very uncertain whether corticosteroid therapy changes number and nature of adverse events secondary to corticosteroid use… compared with no corticosteroid therapy (very low certainty).
1 finding from 1 review
Incidence of mechanical ventilation · individuals with influenza
It is very uncertain whether corticosteroid therapy changes proportion of participants requiring mechanical ventilation compared with no corticosteroid therapy (very low certainty).
1 finding from 1 review
Mortality (respiratory‐ related and all‐cause · adults with acute exacerbations of chronic obstructive pulmonary disease
Titrated oxygen therapy may leads to lower mortality (respiratory‐ related and all‐cause compared with high‐flow oxygen therapy (low certainty).
1 finding from 1 review
Arterial blood gas (pH) · adults with acute exacerbations of chronic obstructive pulmonary disease
1 finding from 1 review
Ventilation of any type · adults with acute exacerbations of chronic obstructive pulmonary disease
Titrated oxygen therapy showed no clear difference in ventilation of any type compared with high‐flow oxygen therapy (low certainty).
1 finding from 1 review
Length of hospital stay · adults with acute exacerbations of chronic obstructive pulmonary disease
1 finding from 1 review
Quality of life ‐ not measured · adults with acute exacerbations of chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Lung function ‐ not measured · adults with acute exacerbations of chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dyspnoea score ‐ not measured · adults with acute exacerbations of chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall survival ( · people with HGG
Anti‐angiogenic therapy showed no clear difference in overall survival ( compared with no anti‐angiogenic therapy (high certainty).
4 findings from 1 review
HR 0.95 [0.88, 1.02]
11 studies · 3743 participants
High
HR 0.93 [0.86, 1.02]
8 studies · 2833 participants
High
HR 0.99 [0.85, 1.16]
3 studies · 910 participants
Moderate
Show 1 more finding
Progression‐free survival · people with HGG
Anti‐angiogenic therapy leads to lower progression‐free survival ( compared with no anti‐angiogenic therapy (high certainty).
4 findings from 1 review
HR 0.73 [0.68, 0.79]
10 studies · 3595 participants
High
HR 0.75 [0.69, 0.82]
8 studies · 2833 participants
High
HR 0.64 [0.54, 0.76]
2 studies · 762 participants
Moderate
Show 1 more finding
Ferritin (µg/L) · people with preoperative anaemia awaiting major surgery
Intravenous iron therapy may leads to higher ferritin preoperatively postintervention (ng/L) compared with oral iron therapy (low certainty).
1 finding from 1 review
Blood transfusion · people with preoperative anaemia awaiting major surgery
The review found no eligible studies for this question.
1 finding from 1 review
QoL · people with preoperative anaemia awaiting major surgery
The review found no eligible studies for this question.
1 finding from 1 review
Haemoglobin (g/dL) · people with preoperative anaemia awaiting major surgery
Intravenous iron therapy may leads to higher haemoglobin levels at end of preoperative treatment (g/dL) compared with oral iron therapy (low certainty).
2 findings from 1 review
CAPS PTSD severity (post‐treatment) ‐ mean difference · adults aged ≥ 16 years with PTSD
1 finding from 1 review
PTSD severity (post‐treatment) ‐ standardized difference · adults aged ≥ 16 years with PTSD
1 finding from 1 review
Dropout from treatment (a count of participants not meeting study‐defined completion threshold) · adults aged ≥ 16 years with PTSD
Present‐centered therapy probably leads to lower treatment dropout compared with trauma‐focused cognitive behavioral therapy (moderate certainty).
1 finding from 1 review